SAN FRANCISCO, Oct. 26, 2016 -- Zephyr Health, the leading Insights-as-a-Service solution provider to Life Sciences companies, today announced it was named as one of the Top 10 Fastest Growing Healthcare Solution Provider Companies by Insights Success for its innovative services and solutions. These include two new game-changing capabilities in Zephyr IlluminateTM – Referral Analytics and Segment Analytics – that revolutionize the way Life Sciences companies use global health data to engage with physicians, accounts, and institutions.
According to Insights Success, Zephyr Health “stays deeply engaged with the industry’s challenges and ahead of the opportunities to ensure that the insights they provide are answering the most pressing questions that their customers need to solve.”
“Having powerful analytical tools to bridge the gap between the abundance of disconnected data and insights-driven decision making is essential for Life Sciences companies to stay relevant in an industry as regulated and competitive as healthcare,” said William King, founder and executive chairman, Zephyr Health. “We are honored to be recognized for leadership in providing predictive insights to help Life Sciences companies make confident decisions faster with data-driven analytics.”
Zephyr Illuminate was cited as a vertical specialist among insights solutions providers in the May 2016 Forrester Research Report, Vendor Landscape: Insights Service Providers, PM360’s Most Innovative Start-ups, 2015, Insights Success’ 20 Most Valuable Enterprise Big Data Companies, 2015 and Gartner’s Cool Vendors in Life Sciences, 2015.
About Insights Success
Insights Success is a top global business magazine for enterprises focusing distinctively on emerging as well as leading fastest growing companies, their confrontational style of doing business and way of delivering effective and collaborative solutions to strengthen market share.
About Zephyr Health
Zephyr Health helps Life Sciences companies – pharmaceutical, biotech, medical device and diagnostics – engage the right physicians, accounts and institutions using insights from global health data. Zephyr Illuminate™ is a leading insights-as-a-service solution that integrates thousands of data sources to create precise and predictive insights. From pre-launch to product maturity, life sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles. Zephyr Health's customers include Top 10 Pharmaceutical companies, Top 10 Biotech Companies and Top 10 Medical Device companies.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures. For more information, please visit: www.zephyrhealth.com.
Media Contact: Zephyr Health Global Communications [email protected]


Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 



